XRX
41
6
FDX
40
4
RIG
58
4
DVN
18
2
MTCH
42
5
COP
54
-2
GM
68
3
LB
41
7
MS
76
2
NUE
58
7
K
57
4
NAVI
47
3
APH
67
3
SYY
49
2
ALL
51
8
MU
36
5
KHC
11
2
EXPE
91
3
MCD
50
-2
PPL
59
5
XRX
41
6
FDX
40
4
RIG
58
4
DVN
18
2
MTCH
42
5
COP
54
-2
GM
68
3
LB
41
7
MS
76
2
NUE
58
7
K
57
4
NAVI
47
3
APH
67
3
SYY
49
2
ALL
51
8
MU
36
5
KHC
11
2
EXPE
91
3
MCD
50
-2
PPL
59
5
Financhill
Back

Terns Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
40

TERN
Terns Pharmaceuticals

Last Price:
5.80
Seasonality Move:
55.51%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
64.22
Seasonality Move:
12.47%
Sell
40
Terns Pharmaceuticals (TERN) is a Sell

Is Terns Pharmaceuticals a Buy, Sell or Hold?

  • The current Terns Pharmaceuticals [TERN] share price is $5.71. The Score for TERN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • TERN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TERN Stock Price Chart

What is Terns Pharmaceuticals's stock price today?

  • The Terns Pharmaceuticals share price today is $5.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TERN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

TERN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 31.42 Sell
Chaikin Money Flow: 607653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.23 - 7.33) Sell
Bollinger Bands (100): (6.7 - 8.98) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 33.54 Sell
Chaikin Money Flow: 933432 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.12 - 69.52) Sell
Bollinger Bands (100): (68.19 - 87.29) Sell

TERN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.2 Sell
20-day SMA: 6.68 Sell
50-day SMA: 7.72 Sell
200-day SMA: 7.14 Sell
8-day EMA: 6.11 Sell
20-day EMA: 6.63 Sell
50-day EMA: 7.24 Sell
200-day EMA: 7.25 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.96 Sell
20-day SMA: 65.96 Sell
50-day SMA: 68.96 Sell
200-day SMA: 81.18 Sell
8-day EMA: 63.79 Sell
20-day EMA: 65.7 Sell
50-day EMA: 69.97 Sell
200-day EMA: 79.54 Sell

Terns Pharmaceuticals Earnings Growth & TERN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.17 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Terns Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):